EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A universal cell-based method for high-throughput analysis of viroporin function and inhibition

Viktoria M S Kjær, Felix Faas, Bo H Bentzen, Mette M Rosenkilde

Pharmacological Research · 2026

DOI: 10.1016/j.phrs.2026.108397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2026. Verfasst von Viktoria M S Kjær und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Translational Pharmacology, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen N 2200, Denmark. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Antiviral Agents, Viral Regulatory and Accessory Proteins, Viral Matrix Proteins. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viroporins are transmembrane proteins encoded mainly by RNA viruses that oligomerize to form pores essential for multiple stages of the viral life cycle. Although they represent attractive antiviral drug targets, progress has been limited in part by the absence of high-throughput approaches to assess viroporin activity and inhibition. Here, we present a novel cell-based, fluorescence-driven method (VipoFluX) that enables high-throughput discovery of viroporins and their characterization, including inhibition in eukaryotic cells. We confirmed the robustness of the method by reproducing datasets from established assays and demonstrating applicability across diverse viroporins. Using this platform, we screened for viroporin inhibitors across four targets (M2 from influenza A virus, E from severe acute respiratory syndrome virus 2, 2B from coxsackievirus B3, vpu from human immunodeficiency virus 1) and validated hits using two-electrode voltage clamp electrophysiology. Overall, this method provides a scalable and versatile tool for advancing viroporin research and accelerating antiviral drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Screening AssaysAntiviral AgentsViral Regulatory and Accessory ProteinsViral Matrix ProteinsViral ProteinsHumansViroporin ProteinsHuman Immunodeficiency Virus ProteinsAnimalsHEK293 Cells

Stichwörter der Autor:innen

AntiviralsHigh-throughput screeningIon channelsMembrane proteinViroporinsVirus

Substanzen

Antiviral AgentsViroporin ProteinsViral Regulatory and Accessory ProteinsViral Matrix ProteinsM2 protein, Influenza A virusvpu protein, Human immunodeficiency virus 1Human Immunodeficiency Virus ProteinsViral Proteins

Autor:innen und Institutionen

  • Molecular and Translational Pharmacology, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen N 2200, Denmark.
  • Molecular Cardiology and Membrane Proteins, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen N 2200, Denmark.
  • Molecular and Translational Pharmacology, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen N 2200, Denmark. Electronic address: rosenkilde@sund.ku.dk.

Förderung

  • European Research Council

Zitieren

APA

Kjær, V. M. S., Faas, F., Bentzen, B. H., & Rosenkilde, M. M. (2026). A universal cell-based method for high-throughput analysis of viroporin function and inhibition. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.108397

Vancouver

Kjær VMS, Faas F, Bentzen BH, Rosenkilde MM. A universal cell-based method for high-throughput analysis of viroporin function and inhibition. Pharmacological Research. 2026. doi:10.1016/j.phrs.2026.108397

BibTeX
@article{Kjr2026,
  author = {Kjær, Viktoria M S and Faas, Felix and Bentzen, Bo H and Rosenkilde, Mette M},
  title = {A universal cell-based method for high-throughput analysis of viroporin function and inhibition},
  journal = {Pharmacological Research},
  year = {2026},
  doi = {10.1016/j.phrs.2026.108397}
}
Kostenlos starten →